US Antimony stock dives 25% as FY26 guidance cut in half
United States Antimony Corporation (NYSE: UAMY) shares fell 25.08% to $4.93 after the company cut its FY26 revenue guidance to $60M-$75M, down from $125M. Q2 EPS came in at breakeven, missing the $0.01 estimate, while sales of $7.93M missed the $21.70M target. HC Wainwright lowered its price target to $9.25. CEO Gary Evans cited delayed government deliveries as the cause for the revenue shortfall, expecting $9M-$10M in Q3 government sales.

*this image is generated using AI for illustrative purposes only.
United States Antimony Corporation (NYSE: UAMY) shares tumbled 25.08% to $4.93 on Wednesday as investors reacted to a severe downgrade in its full-year outlook and disappointing second-quarter financial results. The company slashed its fiscal 2026 revenue guidance to a range of $60 million to $75 million, cutting its prior estimate of $125 million nearly in half and landing well short of the analyst consensus of $114.04 million.
The sell-off was triggered by Q2 earnings that missed Wall Street targets on both top and bottom lines. Earnings per share (EPS) came in at breakeven, falling short of the $0.01 forecast, while quarterly sales totaled approximately $7.93 million, missing the $21.70 million projection by 63.48%. This represents a significant drop from the $10.53 million reported in the same period last year.
Financial Performance Breakdown
| Metric | Reported Value | Estimate | Variance |
|---|---|---|---|
| Earnings Per Share (EPS) | Breakeven | $0.01 | Missed |
| Quarterly Sales | $7.93 million | $21.70 million | Missed by 63.48% |
| Year-Over-Year Sales Change | — | — | Down from $10.53 million |
Despite the revenue shortfall, specific operational metrics showed growth. Antimony pounds sold (exclusive of Defense Logistics Agency sales) rose 26 percent in the quarter. Zeolite revenues surged 110 percent year-over-year, driven by increased demand for industrial minerals used in water filtration and nuclear waste cleanup. Additionally, antimony inventory increased by 178 percent from year-end levels, suggesting preparation for future deliveries.
Operational Context and Outlook
CEO Gary C. Evans framed the quarter as a lag between operational progress and financial results. He noted that while operations have been strengthening monthly, first deliveries to the U.S. Government during the second quarter were not reflected in the financial reporting period. Evans stated that the third quarter should see a minimum of $9 million to $10 million in additional sales, all destined for the U.S. Government, aiming to address the gap between current revenue realization and market expectations.
United States Antimony operates as the only fully integrated antimony company outside of China and Russia, with facilities in Montana and Mexico processing ore into antimony oxide, metal, and trisulfide. The company also mines zeolite at its Bear River facility in Idaho. In 2024 and 2025, it expanded its asset base through acquisitions in Alaska, Montana, and Ontario, Canada, aiming to reduce third-party ore costs.
Analyst Reaction and Technicals
The guidance cut prompted HC Wainwright & Co analyst Heiko Ihle to maintain a Buy rating while lowering the price target to $9.25 from $11.75, a cut of about 21 percent. On the Street, the stock carries a consensus Buy rating with an average price forecast of $10.13.
Technically, UAMY trades 11.9 percent under its 20-day SMA at $5.69, 24.6 percent below its 50-day SMA at $6.65, and more than 36 percent beneath both its 100-day SMA at $8.12 and 200-day SMA at $7.91. The moving-average setup remains bearish with the 20-day below the 50-day, and the July death cross continues to limit rebound strength. However, momentum indicators show the MACD has moved above its signal line with a positive histogram, suggesting selling pressure is easing compared with the previous downswing.
What the Numbers Show
The divergence between the operational volume growth and the revenue miss highlights the volatility inherent in government-dependent supply chains. While inventory buildup and zeolite revenue surges indicate underlying demand, the 63 percent revenue miss underscores execution risks in timing government contract deliveries. The slashed FY26 guidance signals that near-term cash flow visibility remains low despite operational improvements.
Will the anticipated $9-10 million in Q3 U.S. Government sales be sufficient to offset the severe FY26 guidance cut and stabilize investor confidence?
How might the 178% increase in antimony inventory impact future pricing power and margin stability as supply chain dynamics shift?
Can the surging demand for zeolite in water filtration and nuclear waste cleanup become a significant enough revenue driver to diversify away from antimony volatility?





























